Thomas Bahmer reports research support from the German Federal Ministry of Education and Research (BMBF) through the Network University Medicine (NUM) for NAPKON (support code 01KX2021). He further reports unrestricted research grants from the German Center for Lung Research (DZL). He received consulting fees from Thieme (editorial board), HealthHero (expert advice), PneumoLounge (podcast), Pohl Boskamp (expert advice), Pfizer (advisory board), Chiesi (advisory board), and AstraZeneca (advisory board). He also received honoraria for lectures from AstraZeneca, Pohl Boskamp, and Pfizer. He serves as General Secretary of the German Society for Pneumology (DGP). Stefan Schreiber reports consultancy fees from AbbVie, Amgen, Arena, Biogen, BMS, Celgene, Celltrion, Ferring, Fresenius Kabi, Galapagos, Gilead, IMAB, Janssen, Lilly, MSD, Pfizer, Provention Bio, Protagonist, Sandoz/Hexal, Takeda, and Ventyx. He received honoraria for lectures from AbbVie, Alfasigma, Amgen, Arena, Biogen, BMS, Celgene, Celltrion, Falk, Ferring, Fresenius Kabi, Galapagos, Gilead, Hikma, IMAB, Janssen, Lilly, MSD, Pfizer, Provention Bio, Protagonist, Sandoz/Hexal, Takeda, and Ventyx. He also reports travel support from AbbVie, Amgen, Arena, Biogen, BMS, Celgene, Celltrion, Falk, Ferring, Fresenius Kabi, Galapagos, Gilead, IMAB, Janssen, Lilly, MSD, Pfizer, Provention Bio, Protagonist, Sandoz/Hexal, Takeda, and Ventyx. J. Janne Vehreschild reports grants and contracts from Merck/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), German Federal Ministry of Education and Research (BMBF), Deutsches Zentrum für Luft-und Raumfahrt (DLR), University of Bristol, Rigshospitalet Copenhagen, German Network University Medicine, German Cancer Consortium (DKTK), German Federal Ministry of Health (BMG), and the European Union. He received honoraria for lectures from Merck/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, DZIF, University Hospital Freiburg/Congress and Communication, Academy for Infectious Medicine, University Manchester, German Society for Infectious Diseases (DGI), Ärztekammer Nordrhein, Ärztekammer Hessen, University Hospital Aachen, Back Bay Strategies, DGIM, Shionogi, Molecular Health, Netzwerk Universitätsmedizin, Janssen, NordForsk, Biontech, APOGEPHA, DKTK, and University Hospital Oldenburg. He reports travel support from DZIF, University Manchester, DGI, University Hospital Aachen, DGIM, Netzwerk Universitätsmedizin, and DKTK. He has served on advisory boards for Merck/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, DZIF, Academy for Infectious Medicine, University Manchester, DGI, DGIM, Netzwerk Universitätsmedizin, Janssen, and Biontech. Sina Marie Pütz reports honoraria for lectures from Tillotts Pharma GmbH and support for travel from Tillotts Pharma GmbH. Michael Krawczak reports research support from the German Federal Ministry of Education and Research (BMBF) through the NUM NUKLEUS project (grant no. 01KX2121). He further reports serving as Chairman of TMF—Technology and Methods for Networked Medical Research, Berlin. Caroline Morbach reports grants/contracts from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, the German Research Foundation, and the Interdisciplinary Center for Clinical Research Würzburg. She received consulting fees and honoraria for lectures from Alnylam, Pfizer, Boehringer Ingelheim, AstraZeneca, NovoNordisk, Alexion, Janssen, Bayer, Eli Lilly, and Bristol Myers Squibb. She further reports travel support from Alnylam, Pfizer, and Bayer. Clara Lehmann reports grants to her institution from Gilead. She received consulting fees from GSK, Gilead, Biontech, and ViiV. She further reports honoraria for lectures from Gilead, Biontech, Pfizer, and ViiV. She received support for travel from Gilead and has served on advisory boards for Gilead and ViiV. Jens-Peter Reese reports grants or contracts from the German Ministry of Research and Education within NUM (NPKON, NAPOCO, CAEHR, RECAP) and from the Bavarian State Ministry for Science and the Arts (DigiOnko). He received honoraria from the Landesaerztekammer Hessen for an EBM training lecture. He further reports expert testimony for the German Ministry of Health (BMG). Thomas Zoller reports funding for the study from the Federal Ministry of Research and Technology of Germany. Jürgen Deckert reports research support from the German Federal Ministry of Education and Research (BMBF) through the Network University Medicine (NUM) for NAPKON (support code 01KX2021). All other authors have no conflicts of interest to declare.
PubMed